Effective ex vivo inhibition of cryopyrin-associated periodic syndrome (CAPS)-associated mutant NLRP3 inflammasome by MCC950/CRID3

Rheumatology (Oxford). 2022 Oct 6;61(10):e299-e313. doi: 10.1093/rheumatology/keac273.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cryopyrin-Associated Periodic Syndromes* / drug therapy
  • Cryopyrin-Associated Periodic Syndromes* / genetics
  • Furans
  • Humans
  • Indenes*
  • Inflammasomes / genetics
  • Interleukin-1beta
  • NLR Family, Pyrin Domain-Containing 3 Protein / genetics
  • Sulfonamides

Substances

  • Furans
  • Indenes
  • Inflammasomes
  • Interleukin-1beta
  • NLR Family, Pyrin Domain-Containing 3 Protein
  • Sulfonamides
  • N-(1,2,3,5,6,7-hexahydro-S-indacen-4-ylcarbamoyl)-4-(2-hydroxy-2-propanyl)-2-furansulfonamide